HK41697A - Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester - Google Patents

Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester

Info

Publication number
HK41697A
HK41697A HK41697A HK41697A HK41697A HK 41697 A HK41697 A HK 41697A HK 41697 A HK41697 A HK 41697A HK 41697 A HK41697 A HK 41697A HK 41697 A HK41697 A HK 41697A
Authority
HK
Hong Kong
Prior art keywords
methoxyethyl
nitrophenyl
dihydro
dimethyl
special
Prior art date
Application number
HK41697A
Other languages
English (en)
Inventor
Alfons Dr Grunenberg
Ahmed Dr Hegasy
Wolfgang Dr Mueck
Gerhard Dr Franckowiak
Rango-Rao Dr Kanikanti
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK41697A publication Critical patent/HK41697A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
HK41697A 1991-09-11 1997-04-03 Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester HK41697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4130173A DE4130173A1 (de) 1991-09-11 1991-09-11 Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters

Publications (1)

Publication Number Publication Date
HK41697A true HK41697A (en) 1997-04-11

Family

ID=6440342

Family Applications (1)

Application Number Title Priority Date Filing Date
HK41697A HK41697A (en) 1991-09-11 1997-04-03 Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester

Country Status (11)

Country Link
US (1) US5599824A (fr)
EP (1) EP0531845B1 (fr)
JP (1) JPH05229945A (fr)
AT (1) ATE141052T1 (fr)
CA (1) CA2077704C (fr)
DE (2) DE4130173A1 (fr)
DK (1) DK0531845T3 (fr)
ES (1) ES2090432T3 (fr)
GR (1) GR3020962T3 (fr)
HK (1) HK41697A (fr)
MX (1) MX9205077A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
JP4956185B2 (ja) 2003-06-13 2012-06-20 スケンディ ファイナンス リミテッド 避妊及びホルモン補充療法用の調合製剤
CN1824647B (zh) * 2005-02-22 2011-04-20 田边三菱制药株式会社 (±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
WO2018039039A1 (fr) * 2016-08-23 2018-03-01 Edge Therapeutics, Inc. Formulations microparticulaires évolutives contenant la forme polymorphe 2 de nimodipine, préparées par un procédé d'évaporation de solvant
WO2019018306A1 (fr) * 2017-07-17 2019-01-24 Edge Therapeutics, Inc. Formulations microparticulaires évolutives contenant la forme 2 de nimodipine polymorphe micronisée
USD867911S1 (en) * 2018-10-10 2019-11-26 Adel J M S Alabdin Combination gas leak sensor and communication device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932645A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
GB8729471D0 (en) * 1987-12-17 1988-02-03 Wyeth John & Brother Ltd New crystal form

Also Published As

Publication number Publication date
ATE141052T1 (de) 1996-08-15
JPH05229945A (ja) 1993-09-07
DE59206868D1 (de) 1996-09-12
EP0531845B1 (fr) 1996-08-07
DE4130173A1 (de) 1993-03-18
CA2077704A1 (fr) 1993-03-12
DK0531845T3 (da) 1996-11-25
CA2077704C (fr) 2003-03-11
MX9205077A (es) 1993-03-01
ES2090432T3 (es) 1996-10-16
US5599824A (en) 1997-02-04
EP0531845A1 (fr) 1993-03-17
GR3020962T3 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
NZ210866A (en) Asymmetrical diesters of 1,4-dihydro-2, 6-dimethyl-pyridine-3,5-dicarboxylic acid and pharmaceutical compositions
AU5115393A (en) Novel derivatives of taxol analogues, preparation thereof and compositions containing them
HUT40625A (en) Process for preparing dihydropyridine derivatives and pharmaceutical compositions containing such compounds
IL75586A (en) Pharmaceutical compositions containing indole-2-alkanoic acids and derivatives thereof,and certain such novel compounds
AU1114288A (en) N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
IL78939A (en) Pharmaceutical compositions containing n-substituted arylalkyl-and arylalkylene-piperidines and tetrahydropyridines and certain such novel compounds
GR3020962T3 (en) Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester
HUT48872A (en) Process for producing new dihydropyridine derivatives and pharmaceutical compositions comprising same
PT85483A (en) Process for the preparation of novel 1,4-dihydropyridine derivatives with calcium agonist and alpha 1-antagonist activity and of pharmaceutical compositions containing the same
IL75943A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
UA27719C2 (uk) Ефіри 2,6-диметил-1,4-дигідропіридин-3-карбонової кислоти, що є блокаторами кальцієвих каналів, спосіб їх одержання та фармацевтична композиція
HUT60260A (en) Process for producing carbamic acid derivatives of piperidine and pharmaceutical compositions comprising same
IL74071A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
IL104357A0 (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
HUT65253A (en) Process for producing of 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising them
IL82294A (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL94645A0 (en) Preparation of n-oxo-tetrahydro-beta-carbolines,certain such novel compounds and pharmaceutical compositions containing them
HUT50329A (en) Process for producing 4-piperidinylmethyl derivatives of 2,3-dihydro-1h-isoindole and of 2,3,4,5-tetrahydro-1h-benzazepines and pharmaceutical compositions
EP0445987A3 (en) Novel process for producing 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-3-methyl ester-5-beta-(n-benzyl-n-methylamino)ethyl ester
IL101735A0 (en) Octahydrobenzo(g)quinoline,its production and pharmaceutical compositions containing it
EP0167068A3 (en) Isopropyl-2û2-(3-trifluoromethylphenoxy)ethyl¨ester of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylic acid, process for its preparation, and its use as a medicine
IL106369A0 (en) A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
IL92759A0 (en) Pharmaceutical compositions containing 1,2,3,4-tetrahydroacridine derivatives and certain such novel compounds
PT80719A (en) Process for the preparation of dihydropyridine derivatives and of pharmaceutical compositions containing the same
IL86108A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
AS Change of ownership

Owner name: BAYER HEALTHCARE AG

Free format text: FORMER OWNER(S): BAYER AG

CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20120830